Best in Biotech 24 Oct 2024
Six biotech companies advancing multiple sclerosis therapies
Take a look at six multiple sclerosis companies trying to make a difference to patients by advancing new treatments for the CNS disease.
Funding
- Latest Posts
News and Trends 21 Oct 2024
Turning back time with cellular reprogramming: Shift raises $16 million in seed funding
As Shift Bioscience raises $16 million in seed funding, delve into the field of cellular reprogramming to tackle age-related diseases.
News and Trends 15 Oct 2024
Booster launches to treat neurodegenerative diseases with proteasome activation
Discover Booster Therapeutics’ novel proteasome activation approach to neurodegenerative diseases as it launches with $15 million.
Expert Advice 11 Oct 2024
How to build your biotech company in 2024 (according to founders)
Discover the insight successful biotech founders share with us to build your biotech company – from building your team to attracting funding.
News and Trends 10 Oct 2024
Second biotech IPO boom of the year: what does it mean for the industry?
Discover why biotech is experiencing a second IPO boom in 2024 and what it means for the broader industry.
Best in Biotech 10 Oct 2024
12 biotech unicorns revolutionizing the future of healthcare
Take a closer look at 12 biotech unicorns, with a worth of more than $1 billion, that are trying to revolutionize the biopharma industry.
ADVERTISEMENT
ADVERTISEMENT
In Depth 4 Oct 2024
The biggest private biotech investments in September 2024
The companies Candid Therapeutics, ArsenalBio, and eGenesis bagged the biggest private biotech investments in September 2024.
News and Trends 3 Oct 2024
Resolution Therapeutics raises $85 million to advance its macrophage therapy
Find out about Resolution Therapeutics’ macrophage therapy, as it just raised $85 million in a series B round.
Best in Biotech 1 Oct 2024
Lithuania’s biotech: Six companies to put on your radar
Here are six companies at the forefront of Lithuania’s growing biotech scene, showcasing innovations in protein engineering and gene editing.
News and Trends 30 Sep 2024
The race for a bird flu vaccine: milestones and breakthroughs
The recent uptick in U.S. bird flu cases poses a threat to public health. Biotechs are now developing vaccines to mitigate the outbreak.
Best in Biotech 26 Sep 2024
Europe’s rising biotech stars: 10 startups to watch in 2024
The European biotech industry is bustling with activity this year. Here’s a list of 10 European biotech companies likely to make a big splash.
News and Trends 23 Sep 2024
Vicebio and its molecular clamp vaccine raise big to tackle respiratory viruses
Discover Vicebio’s molecular clamp technology as it completes a $100 million series B round for its bivalent vaccine against RSV and hMPV.
ADVERTISEMENT
